China Biologic Products Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

CBPO 69.23 +0.93 (1.36%)
price chart
Update: China Biologic Products Q3 Earnings Beat (CBPO)
Before Q2 earnings on August 5, I wrote a bullish article on China Biologic Products (NASDAQ:CBPO), with a thesis stating that the company's plasma-based products should benefit from increasing market demand in China for Q2. I argued that the company's ...
Related articles »  
China Biologic Products Becomes Oversold (CBPO)
In trading on Monday, shares of China Biologic Products Inc (NASD: CBPO) entered into oversold territory, hitting an RSI reading of 29.1, after changing hands as low as $49.11 per share.
Related articles »  
Brokerage Firm Price Target on China Biologic Products Inc
Equity Analysts at the Jefferies maintains the rating on China Biologic Products Inc (NASDAQ:CBPO). The brokerage firm has issued a Buy rating on the shares.
China Biologic Products Upgraded by Zacks to "Outperform" (CBPO)
China Biologic Products Inc logo Zacks upgraded shares of China Biologic Products (NASDAQ:CBPO) from a neutral rating to an outperform rating in a research note released on Monday morning.
China Biologic Products Rating Increased to Outperform at Zacks (CBPO)  Mideast Time
Stocks Appreciate for the Week: Limoneira Co , China Biologic Products Inc  Winston View
China Biologic Products Earnings Preview (CBPO)
China Biologic Products (NASDAQ: CBPO), a biopharmaceutical company focused on developing plasma-based products, has been subjected to a roller coaster ride over the last several months. Back in mid June, shares fell more than 11% after the ...
Related articles »  
China Biologic Products Inc
China Biologic Products, Inc. was originally incorporated on December 20, 1989 under the laws of the State of Texas as Shepherd Food Equipment, Inc. On November 20, 2000, Shepherd Food Equipment, Inc. changed its corporate name to Sh...moreepherd ...
Six Reasons to Buy China Biologic Products
China Biologic used to have only one operating subsidiary, Shandong Taibang. By the end of 2008, with the acquisition of Guiyang Dalin and a 35% equity interest in Xi'an Huitian, China Biologic became the largest non-state owned company in China's ...
China Biologic Presents A Unique Investment Opportunity
Undoubtedly, both China Biologic's majority stake in Guizhou and its two successive quarters of rising product revenues are healthy signs of a rapidly growing healthcare company. Nevertheless, with such impressive growth and incredible stock ...
Why China Biologic Products (CBPO) Could Be an Impressive Growth Stock
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors' attention, and produce big gains as well.
Related articles »  
China Biologic Products (CBPO) CEO David Gao on Q2 2014 Results - Earnings ...
China Biologic Products (CBPO) CEO David Gao on Q2 2014 Results - Earnings Call Transcript. Aug. 10, 2014 10:18 PM ET | About: China Biologic Products, Inc. (CBPO) by: SA Transcripts. China Biologic Products, Inc. (NASDAQ:CBPO). Q2 2014 Earnings ...